HSCS

HeartSciences Inc. · NASDAQ · Healthcare · USD · 10-K for 2026, filed 2026-07-23

Figures on this page computed 2026-11-08 12:40 UTC

Last close

3.10USD

Market data, 2026-11-04

Except where said otherwise: 10-K for 2026, filed 2026-07-23

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2026
Accession
0001437749-26-024337
Reported in
USD
- computed
- 10-K for 2026, filed 2026-07-23
The filing itself
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2026
Accession
0001437749-26-024337
Reported in
USD
- 10-K for 2026, filed 2026-07-23
- 10-K for 2026, filed 2026-07-23
- 10-K for 2026, filed 2026-07-23
- 10-Q for 2026, filed 2026-09-14
- 10-K for 2026, filed 2026-07-23
- 10-Q for 2026, filed 2026-09-14
The filing itself
-211666.5%Net margin
Net Income / Revenue x 100
Source
computed
Fiscal year
2026
Accession
0001437749-26-024337
Reported in
USD
- 10-K for 2026, filed 2026-07-23
- 10-K for 2026, filed 2026-07-23
The filing itself
-172036.6%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2026
Accession
0001437749-26-024337
Reported in
USD
- 10-K for 2026, filed 2026-07-23
- 10-K for 2026, filed 2026-07-23
The filing itself
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2026
Accession
0001437749-26-024337
Reported in
USD
- 10-K for 2026, filed 2026-07-23
- 10-Q for 2026, filed 2026-09-14
The filing itself
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Safety is the furthest below its sector's middle: 0.05 against 0.52 on the market's range.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Five bars, one line

lens 7 of 9

0.22x

1.53x

1.42x

n/a

0.07x

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Filed2026

Market data2026-11-04

Each against its own average

4 of 5 read

Except where said otherwise: 10-K for 2026, filed 2026-07-23

Sales0.22x
Its own average over 7 years, 19.5K.
Profit1.53x
Its own average over 7 years, -6.0M.
Free cash flow1.42x
Its own average over 7 years, -5.2M.
Debtn/a
Its own average over 2 years, 2.0M.
Price0.07x
Its own average over 5 years, 43. Market data, 2026-11-04

Price is furthest from its own average, at 0.07 times.

Sales is 0.22 times its own 7-year average; Profit is 1.53 times its own 7-year average; Free cash flow is 1.42 times its own 7-year average; Price is 0.07 times its own 5-year average.

Every figure in this lens

Except where said otherwise: 10-K for 2026, filed 2026-07-23

Sales against its own 7-year average0.22
Source
filed
Statement
income
Fiscal year
2026
Accession
0001437749-26-024337
Reported in
USD
The filing itself
Profit against its own 7-year average1.53
Source
filed
Statement
income
Fiscal year
2026
Accession
0001437749-26-024337
Reported in
USD
The filing itself
Free cash flow against its own 7-year average1.42
Source
filed
Statement
income
Fiscal year
2026
Accession
0001437749-26-024337
Reported in
USD
The filing itself
Debt against its own 2-year averagen/a
Not held.
Source
filed
Statement
income
Fiscal year
2026
Accession
0001437749-26-024337
Reported in
USD
The filing itself
Price against its own 5-year average0.07Market data, 2026-11-04
Source
market
Taken on
2026-11-04
Reported in
USD